BVS
Bioventus·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BVS fundamentals
Bioventus (BVS) released its earnings on Nov 4, 2025: revenue was 138.70M (YoY -0.22%), beat estimates; EPS was 0.15 (YoY +314.29%), beat estimates.
Revenue / YoY
138.70M
-0.22%
EPS / YoY
0.15
+314.29%
Report date
Nov 4, 2025
BVS Earnings Call Summary for Q3,2025
- Q3 Execution: 8% organic growth, 19% EBITDA margin, $30M cash flow, validating 2025 guidance.
- New Product Momentum: PNS/PRP set to accelerate 2026+ growth.
- Balance Sheet Strength: <3x leverage, $42M cash, $300M+ debt reduction.
- Risk Management: Tariffs/FX hedged by operational excellence.
- 2025-2026 Transition: 2025 execution risk/reward balanced.
EPS
Revenue
Revenue & Expenses
BVS has released its 2025 Q3 earnings report, with revenue of 138.65M, reflecting a YoY change of -0.23%, and net profit of 4.01M, showing a YoY change of 168.50%. The Sankey diagram below clearly presents BVS's revenue sources and cost distribution.
Key Indicators
Bioventus (BVS) key financial stats and ratios, covering profitability, financial health, and leverage.
Bioventus (BVS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Bioventus (BVS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Bioventus (BVS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Bioventus (BVS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Bioventus (BVS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Bioventus's earnings call?What is the market's earnings forecast for Bioventus next quarter?What does Bioventus do and what are its main business segments?What guidance did Bioventus's management provide for the next earnings period?Did Bioventus beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Bioventus year over year?What is Bioventus's latest dividend and current dividend yield?What were the key takeaways from Bioventus’s earnings call?
